A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer
Clinical trial NCT03206073 · COMPLETED
Trial details
- NCT number
- NCT03206073
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2020-09-24
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.